Thomas Defay

Thomas Defay

Company: Alexion, AstraZeneca Rare Disease

Job title: Deputy Head, Diagnostics Strategy and Development


Leveraging Novel Newborn Whole Genome Sequencing to Enable Screening & Diagnosis of Disease 11:30 am

Accelerating treatment of over 500 diseases by leveraging newborn sequencing technologies  Achieving faster molecular diagnosis using whole genome sequencing Bridging bioinformatics, data science, genomics and molecular sciences to bring newborn screening practices up to speedRead more

day: Day 2 Track C AM

Fireside Chat: Harnessing the Genomics of Cancer: What Can We Learn from Orphan Drug Developers? 3:00 pm

Is it time to treat cancer as a rare disease? Meet us at the intersection of cancer and orphan drug development for a candid discussion on how evolving genomic approaches for rare diseases can help advance clinical biomarker discovery and companion diagnostics for cancer precision medicines.Read more

day: Day 1 Track C PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.